Lista de obras -

A new model for blunt liver injuries in the swine

scientific article published on 09 December 2009

Antifouling Microparticles To Scavenge Lipopolysaccharide from Human Blood Plasma

scientific article published on 22 January 2019

Automatic Control of Veno-Venous Extracorporeal Lung Assist

artículo científico publicado en 2016

Coagulation Management in Jersey Calves: An ex vivo Study

artículo científico publicado en 2017

Coagulation factor concentrates and point-of-care coagulation monitoring: both might be essential for optimal treatment of trauma-induced coagulopathy.

artículo científico publicado en 2017

Comparing the viscoelastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one?

artículo científico publicado en 2016

Comparison between the new fully automated viscoelastic coagulation analysers TEG 6s and ROTEM Sigma in trauma patients: A prospective observational study

artículo científico publicado en 2019

Correction to: Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

artículo científico publicado en 2017

Cortisol and alpha-amylase as stress response indicators during pre-hospital emergency medicine training with repetitive high-fidelity simulation and scenarios with standardized patients

artículo científico publicado en 2015

Direct Oral Anticoagulants in Emergency Trauma Admissions.

artículo científico publicado en 2016

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding

artículo científico publicado en 2017

Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model

artículo científico publicado en 2015

Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model.

artículo científico publicado en 2015

Evaluation of combined idarucizumab and prothrombin complex concentrate treatment for bleeding related to dabigatran in a lethal porcine model of double trauma

artículo científico publicado en 2018

Fibrin patch in a pig model with blunt liver injury under severe hypothermia.

artículo científico publicado en 2013

Fibrinogen Supplementation and Its Indications

artículo científico publicado en 2019

Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model

scientific article published on 01 October 2014

Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors

artículo científico publicado en 2019

Glasgow Coma Scale and laboratory markers are superior to COHb in predicting CO intoxication severity

artículo científico publicado en 2010

Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury

artículo científico publicado en 2016

Idarucizumab in major trauma patients: a single centre real life experience

artículo científico publicado en 2019

Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation

artículo científico publicado en 2015

Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.

artículo científico publicado en 2016

Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects

artículo científico publicado en 2016

Impact of Direct Oral Anticoagulants (DOACs) in Patients with Hip Fractures

artículo científico publicado en 2019

In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran

In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices

artículo científico publicado en 2018

Influence of a freeze-thaw cycle on the stress-stretch curves of tissues of porcine abdominal organs

scientific article published on 04 August 2012

Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.

artículo científico publicado en 2009

Is "Thrombin Burst" Now the Worst Option in Trauma?

artículo científico publicado en 2017

Management of hemorrhage in patients treated with direct oral anticoagulants

artículo científico publicado en 2017

Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays

artículo científico publicado en 2014

Microfluidic cell sorting: Towards improved biocompatibility of extracorporeal lung assist devices.

artículo científico publicado en 2018

Nonsurgical techniques to control massive bleeding.

artículo científico publicado en 2012

Perioperatively acquired disorders of coagulation.

artículo científico publicado en 2015

Plasma-derived Factor X therapy for treatment of intracranial bleeding in a patient with Factor X deficiency: a case report

artículo científico publicado en 2019

Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.

artículo científico publicado en 2014

Porcine blood and surrogate markers do not prove benefit of aDabi-Fab. Authors' response

Pre-hospital plasma transfusion: a valuable coagulation support or an expensive fluid therapy?

artículo científico publicado en 2019

Prothrombin Complex Concentrate Is Effective in Treating the Anticoagulant Effects of Dabigatran in a Porcine Polytrauma Model.

artículo científico publicado en 2015

Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model

artículo científico publicado en 2019

Prothrombin complex concentrate (PCC) for the treatment of coagulopathy associated with massive bleeding

scientific article published on 01 December 2010

Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia

artículo científico publicado en 2011

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model

artículo científico publicado en 2014

Prothrombin complex concentrates in trauma and perioperative bleeding

artículo científico

Re: Three versus four-factor prothrombin complex concentrates for "factor-based" resuscitation in a porcine hemorrhagic shock model.

artículo científico publicado en 2018

Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia

artículo científico publicado en 2015

Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs

scientific article published on 06 October 2010

Reply to Faraoni D, Fenger-Eriksen C, Gillard S et al. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study

artículo científico publicado en 2015

Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.

artículo científico publicado en 2015

Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model

artículo científico publicado en 2018

Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma

artículo científico publicado en 2017

Rotational thromboelastometry for the diagnosis of coagulation disorders

artículo científico publicado en 2016

Safer in everyday clinical care

artículo científico publicado en 2015

Septic porcine blood does not further activate coagulation during in vitro membrane oxygenation.

artículo científico publicado en 2016

Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

artículo científico publicado en 2016

Supplementary fibrinogen in the management of bleeding: re-evaluation of data from clinical trials.

artículo científico publicado en 2017

Survival of HeartMate II Patients Despite Cessation of Anticoagulation　- Outcomes and Hemostatic Analysis

artículo científico publicado en 2017

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination

scientific article published on 13 March 2018

The Reversal of Direct Oral Anticoagulants in Animal Models

artículo científico publicado en 2017

The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old.

artículo científico publicado en 2018

The relevance of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration for postoperative infections and postoperative organ dysfunctions in cardiac surgery patients: The eVIDenCe study

scientific article published on 13 December 2018

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate.

artículo científico

Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review

artículo científico publicado en 2017

Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model.

artículo científico publicado en 2015

Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model.

artículo científico publicado en 2013

Tissue oxygen saturation as an early indicator of delayed lactate clearance after cardiac surgery: a prospective observational study.

artículo científico publicado en 2015

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model

artículo científico publicado en 2019

Twelve Hours In Vitro Biocompatibility Testing of Membrane Oxygenators.

artículo científico publicado en 2015

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs

artículo científico publicado en 2014

Virtual reality-based simulator for training in regional anaesthesia.

artículo científico publicado en 2009

Visualization of fibrinogen-dependent thrombus formation*.

artículo científico publicado en 2013

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution

artículo científico publicado en 2019

[Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.]

artículo científico publicado en 2016

[Dealing with massive bleeding and associated perioperative coagulopathy: recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine]

scientific article published on 01 March 2013

[Individualized coagulation therapy: Wish or already reality?]

artículo científico publicado en 2015

[Prehospital plasma transfusion in civilian trauma patients in hemorrhagic shock]

artículo científico publicado en 2018

[Treatment of massive bleeding: summary of the updated European guidelines]

artículo científico publicado en 2011

Lista de obras de

A new model for blunt liver injuries in the swine

Antifouling Microparticles To Scavenge Lipopolysaccharide from Human Blood Plasma

Automatic Control of Veno-Venous Extracorporeal Lung Assist

Coagulation Management in Jersey Calves: An ex vivo Study

Coagulation factor concentrates and point-of-care coagulation monitoring: both might be essential for optimal treatment of trauma-induced coagulopathy.

Comparing the viscoelastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one?

Comparison between the new fully automated viscoelastic coagulation analysers TEG 6s and ROTEM Sigma in trauma patients: A prospective observational study

Correction to: Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

Cortisol and alpha-amylase as stress response indicators during pre-hospital emergency medicine training with repetitive high-fidelity simulation and scenarios with standardized patients

Direct Oral Anticoagulants in Emergency Trauma Admissions.

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding

Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model

Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model.

Evaluation of combined idarucizumab and prothrombin complex concentrate treatment for bleeding related to dabigatran in a lethal porcine model of double trauma

Fibrin patch in a pig model with blunt liver injury under severe hypothermia.

Fibrinogen Supplementation and Its Indications

Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model

Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors

Glasgow Coma Scale and laboratory markers are superior to COHb in predicting CO intoxication severity

Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury

Idarucizumab in major trauma patients: a single centre real life experience

Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation

Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.

Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects

Impact of Direct Oral Anticoagulants (DOACs) in Patients with Hip Fractures

In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran

In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices

Influence of a freeze-thaw cycle on the stress-stretch curves of tissues of porcine abdominal organs

Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.

Is "Thrombin Burst" Now the Worst Option in Trauma?

Management of hemorrhage in patients treated with direct oral anticoagulants

Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays

Microfluidic cell sorting: Towards improved biocompatibility of extracorporeal lung assist devices.

Nonsurgical techniques to control massive bleeding.

Perioperatively acquired disorders of coagulation.

Plasma-derived Factor X therapy for treatment of intracranial bleeding in a patient with Factor X deficiency: a case report

Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.

Porcine blood and surrogate markers do not prove benefit of aDabi-Fab. Authors' response

Pre-hospital plasma transfusion: a valuable coagulation support or an expensive fluid therapy?

Prothrombin Complex Concentrate Is Effective in Treating the Anticoagulant Effects of Dabigatran in a Porcine Polytrauma Model.

Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model

Prothrombin complex concentrate (PCC) for the treatment of coagulopathy associated with massive bleeding

Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model

Prothrombin complex concentrates in trauma and perioperative bleeding

Re: Three versus four-factor prothrombin complex concentrates for "factor-based" resuscitation in a porcine hemorrhagic shock model.

Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia

Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs

Reply to Faraoni D, Fenger-Eriksen C, Gillard S et al. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study

Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.

Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model

Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma

Rotational thromboelastometry for the diagnosis of coagulation disorders

Safer in everyday clinical care

Septic porcine blood does not further activate coagulation during in vitro membrane oxygenation.

Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

Supplementary fibrinogen in the management of bleeding: re-evaluation of data from clinical trials.

Survival of HeartMate II Patients Despite Cessation of Anticoagulation - Outcomes and Hemostatic Analysis

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination

The Reversal of Direct Oral Anticoagulants in Animal Models

The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old.

The relevance of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration for postoperative infections and postoperative organ dysfunctions in cardiac surgery patients: The eVIDenCe study

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate.

Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review

Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model.

Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model.

Tissue oxygen saturation as an early indicator of delayed lactate clearance after cardiac surgery: a prospective observational study.

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model

Twelve Hours In Vitro Biocompatibility Testing of Membrane Oxygenators.

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs

Virtual reality-based simulator for training in regional anaesthesia.

Visualization of fibrinogen-dependent thrombus formation*.

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution

[Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.]

[Dealing with massive bleeding and associated perioperative coagulopathy: recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine]

[Individualized coagulation therapy: Wish or already reality?]

[Prehospital plasma transfusion in civilian trauma patients in hemorrhagic shock]

[Treatment of massive bleeding: summary of the updated European guidelines]

Survival of HeartMate II Patients Despite Cessation of Anticoagulation　- Outcomes and Hemostatic Analysis